Skip to content

Postoperative Pain and Polyamines-poor Diet (DOLAMINE)

Impact on Pain of a Preoperative Polyamines-poor Diet After Orthopedic Surgery of the Foot

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02592460
Acronym
DOLAMINE
Enrollment
542
Registered
2015-10-30
Start date
2014-12-31
Completion date
2017-07-31
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Animal studies have shown that the level of pain sensitivity is highly dependent on the amount of polyamines in food. This fundamental observation of a nutritional approach to pain led the authors to develop diets completely depleted in polyamines whose anti-nociceptive properties have been confirmed in animals. Postoperative pain after foot surgery are currently fairly well controlled but at the cost of a high consumption of grade II analgesics which is associated with a high rate of side effects (nausea, vomiting ...). The investigators' hypothesis is that a diet low in polyamines may have an additive effect on pain control and reduce the consumption of level 2 analgesics. The objective of this study is to show the efficacy of a polyamines-poor diet on postoperative pain in ambulatory surgery of the foot.

Interventions

OTHERpoor-polyamines diet

Patients in this will receive a poor-polyamines diet during a week before and a week after foot surgery

OTHERhigh polyamines diet

Patients in this will receive a high-polyamines diet during a week before and a week after foot surgery

Sponsors

Groupe Hospitalier Diaconesses Croix Saint-Simon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* foot ambulatory orthopedic surgery * surgery scheduled at least 10 days after the inclusion consultation

Exclusion criteria

* other diet susceptible to interfere with the poor or high-polyamines diets (e.g. diabetic patients) * contraindication to tramadol or to NSAIDs * pregnant or breastfeeding woman * patient under legal protection * patient's opposition to participate in the study * poor understanding of French * absence of affiliation to social security * participation to another study

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients whose worst pain, as measured on an visual analogic scale ranging from 0 mm to 100 mm, was at least once rated as 30 mm or more.Eight days after surgeryThe worst pain will be assessed retrospectively the eighth day after surgery

Secondary

MeasureTime frameDescription
Percentage of patients with a need for grade II analgesicsEighth day after surgery
Overall tramadol consumption , expressed in mg.Eight days after surgery
Worst pain, expressed in mm, measured on an visual analogic scale ranging from 0 mm to 100 mmEight days after surgeryThe worst pain will be assessed retrospectively the eighth day after surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026